Table 8.

Health-related quality of life (short form-36) among coronavirus disease 2019 survivors (n=60) who did not require intensive care unit admission at 3, and 6 months after illness onset in comparison with normative data stratified into different age groups

SF-36 domains/age group (years)	Normal, mean±SD	3 months versus normal, mean±SD; mean (95% CI)	6 months versus normal, mean±SD; mean (95% CI)
PF
18-40	96.3±6.6	82.8±15.8; −13.5 (−16.0-−7.0)*	88.1±16.5; −8.2 (−13.4-−5.2)*
41-60	90.6±12.4	59.5±24.6; −31.1 (−42.2-−15.8)*	64.1±25.6; −26.6 (−40.2-−12.9)*
RP
18-40	85.6±27.7	59.7±41.8; −25.9 (−45.7-−20.4)*	70.0±40.7; −15.6 (−20.1-0.1)*
41-60	81.6±31.7	38.1±32.8; −43.5 (69.3-−35.7)*	28.1±41.7; −53.5 (−75.9-−37.6)*
BP
18-40	86.4±19.4	70.2±22.2; −16.2 (−22.5-−2.1)*	76.9±25.8; −9.5 (−20.6-−8.9)*
41-60	82.6±22.9	42.9±18.7; −39.7 (−51.0-−28.3)*	47.7±24.9; −34.9 (−48.2-15.2)*
GH
18-40	59.5±19.4	58.2 (14.4); −1.3 ( −6.1-2.9) (NS)	58.4±18.8; −1.1 (−8.6-2.1) (NS)
41-60	53.2±20.1	40.3 (11.6); −13.0 (−17.6-−5.3)*	36.3±16.5; −16.9 (−23.3-−7.1)*
VT
18-40	60.2±18.3	45.8±11.2; −14.4 (−18-−6.8)*	49.5±11.2; −10.7 (−16.0-−9.4)*
41-60	60.3±18.9	39.7±9.6; −20.6 (−35.5-−15.2)*	38.1±15.5; −22.2 (−35.5-−14.9)*
SF
18-40	90.2±16.2	74.0±11.9; −16.2 (−24.5-−10.3)*	75.0±12.8; −15.3 (−26.4-−8.6)*
41-60	92.4±16.5	53.9±25.7; −38.5 (−55.8-−26.8)*	59.4±29.8; −33.0 (−49.0-−17.4)*
RE
18-40	67.7±39.4	66.0±41.8; −1.7 (−12.9-5.4) (NS)	76.0±34.4; 8.3 (−2.8-0.207) (NS)
41-60	75.0±37.0	32.7±38.9; −42.3 (−65.9-−20.0)*	46.8±46.7; −28.2 (−46.1-−13.7)*
MH
18-40	71.8±15.6	69.6±16.9; −2.2 (−8.9-3.2) (NS)	67.0±15.1; −4.8 (−8.7-−1.2)*
41-60	73.1±17.6	50.8±16.3; −22.3 (−30.0-−12.0)*	55.0±16.7; −18.1 (−25.6-−10.2)*

*Significant at P<0.05. Normal range: Based on the study by Lam et al.^[14] NS=Not significant, PF=Physical functioning, RP=Role physical, BP=Body pain, GH=General health, VT=Vitality, SF=Social functioning, RE=Role emotional, MH=Mental health, SF-36=Short form-36, CI=Confidence interval, SD=Standard deviation